EUVIMEDEUVIMED entdecken
Leitlinie

Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies

Janhavi Venkataraman, Muharrem Oner, Kefah Mokbel

Breast Communications · 2025

DOI: 10.21037/bc-25-17 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Breast Communications, 2025. Verfasst von Janhavi Venkataraman und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Venkataraman, J., Oner, M., & Mokbel, K. (2025). Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies. Breast Communications. https://doi.org/10.21037/bc-25-17

Vancouver

Venkataraman J, Oner M, Mokbel K. Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies. Breast Communications. 2025. doi:10.21037/bc-25-17

BibTeX
@article{Venkataraman2025,
  author = {Venkataraman, Janhavi and Oner, Muharrem and Mokbel, Kefah},
  title = {Reevaluating guideline concordance in inflammatory breast cancer: addressing unrecognized complexities and evolving therapeutic strategies},
  journal = {Breast Communications},
  year = {2025},
  doi = {10.21037/bc-25-17}
}
Kostenlos starten →